IRCCS Centro S. Giovanni di Dio Fatebenefratelli

Brescia 25125

0 studies enrolling now · 4 studies all time

What they study most

Alzheimer Disease, Frontotemporal Dementia, Granulin Mutation, Neurodegenerative Diseases

Studies at this site

• A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3) — Stopped early
• Continuation Study for Latozinemab — Stopped early
• Safety and Efficacy of TRx0237 in Subjects With Alzheimer's Disease Followed by Open-Label Treatment — Completed
• Study to Assess the Safety, Tolerability, and Pharmacodynamic (PD) Effects of FRM-0334 in Subjects With Prodromal to Moderate Frontotemporal Dementia With Granulin Mutation — Status unconfirmed